This glossary is designed to explain some of the scientific terminology, abbreviations etc. used by some people when they talk about autism or research.

You may be able to find more information, including links to other parts of this website, by clicking on the title of an item.
If you can’t find the word you are looking for, or you know of a word we should include, please email info@researchautism.net
The fact that an intervention is listed in this glossary does not necessarily mean that we agree with its use. Nor does it necessarily mean that there is any scientifically valid or reliable evidence behind it.
Over time we hope to evaluate each of the interventions listed in this glossary, providing a ranking which tells you the level of scientific evidence which supports or does not support its use. For more information please see Treatments and Therapies for Autism Currently Under Scientific Evaluation by Research Autism
Carbamazepine is a type of anticonvulsant sold under various brand names including Biston®, Calepsin®, Carbatrol®, Epitol®, Equetro®, and Tegretol®.
Carbamazepine is used to to prevent or reduce the severity of seizures. It is also used to treat trigeminal neuralgia, episodes of mania, and mixed episodes of mania and depression.
Some people believe that some anticonvulsants can also be used to reduce some of the core symptoms of autism, such as social and communication difficulties and repetitive, compulsive behaviour.
Please note that carbamazepine can produce significant and hazardous side effects in some people, including life-threatening allergic reactions called Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN).
There are 11 publications related to "Carbamazepine", please click here to view the list (new window)